ANDERSON DANIEL GRIFFITH sold 9.0% of their position (200K shares) of SIGILON THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.00M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/4/2021ACC: 0001415889-21-002817
Director
Since Dec 2020
-200K
Net shares
Net seller
$2.00M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
200K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−200K
Price / share
$10.00
Trade value
$2M
% of position
9.0%
6/2/2021
2.22M→2.02M
Total
Net shares
−200K
Net value
-$2M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/2/2021 | S · Sale | −200K | $10.00 | $2M | 9.0% | 2.22M | 2.02M |
| Total | −200K | -$2M | ||||||
Derivative Transactions0
No derivative transactions reported